Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Governance topic
No spam. Unsubscribe anytime.
PDAB adopts revised Policies and Procedures in unanimous vote
Summary
The Oregon Prescription Drug Affordability Board voted 5–0 to adopt amendments to its Policies and Procedures 01, approving revisions posted in the meeting materials and on the PDAB website.
Get email alerts on the Governance topic
No spam. Unsubscribe anytime.
The Oregon Prescription Drug Affordability Board voted 5–0 on Feb. 18, 2026, to adopt amendments to its Policies and Procedures 01. Dan Kennedy moved to accept the revisions and Michele Koder seconded; the motion passed with Lauri Hoagland, Dan Kennedy, Michele Koder, Chris Laman and Acting Chair Dan Hartung voting yes.
The board reviewed the amended Policies and Procedures 01, which are shown on Pages 11–16 of the agenda materials and have been posted on the PDAB website. The minutes record the formal motion language: "MOTION to accept the revisions to our policy (Policies and Procedures 01) as amended." The board listed no declarations of conflict of interest for this vote.
The adoption completes the board's annual policy review step for Policies and Procedures 01. The board did not specify substantive regulatory changes in the meeting minutes; the revised document is available in the posted agenda materials. The board's next regular meeting is March 18, 2026, when other items including the final drug review report are scheduled for vote.
